756 | 合法藥品大搜索

由 KE Davidson 著作 · 2018 · 被引用 14 次 — Administration of lacosamide via IV push results in similar adverse effect rates to IV piggyback preparations with more efficient time to administration. Read More

VIMPAT injection for intravenous use—indicated as short-term replacement when oral administration is not feasible. The safety of VIMPAT injection in pediatric ... Read More

VIMPAT may be initiated in adult patients with a single loading dose of 200 mg (​oral or injection) followed approximately 12 hours later by 100 mg twice-daily (​200 ... Read More

由 KE Davidson 著作 · 2018 · 被引用 1 次 — Learning Objectives: Intravenous (IV) lacosamide (LCM) use for status epilepticus ... Administration undiluted as an IV push has potential to increase efficiency of ... Read More

由 KE Davidson 著作 · 2018 · 被引用 1 次 — All IV push doses were administered at a rate of 80 mg/min. Baseline characteristics, data related to potential safety concerns and timing of order verification and ... Read More

The overall duration of treatment with intravenous lacosamide is at the physician's discretion; there is experience from clinical studies with twice daily infusions of ... Read More

Administration · Administer by IV infusion over 30-60 minutes; May administer as rapidly as 15 minutes if needed · Administer by IV infusion over 30-60 minutes ... Read More

由 KE Davidson 著作 · 2018 · 被引用 14 次 — In January 2017, a protocol change allowed physician ordering and nursing administration of lacosamide via IV push at a rate of 80 mg/min, with ... Read More

2008年10月28日 — At the end of the intravenous treatment period, the patient may be switched to VIMPAT oral administration at the equivalent daily dosage and ... Read More

由 K McLaughlin 著作 · 2021 · 被引用 2 次 — Infusion site reaction rates of 1.80% and 0.84% were documented in the IVP and IVPB cohorts, respectively (P = 0.33). Of note, only 1 adverse ... Read More